Suppr超能文献

动脉粥样硬化性疾病:发病机制与治疗方法。

Atherosclerotic Disease: Pathogenesis and Approaches to Management.

机构信息

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232, USA.

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 300, Nashville, TN 37203, USA.

出版信息

Med Clin North Am. 2023 Sep;107(5):793-805. doi: 10.1016/j.mcna.2023.04.004. Epub 2023 Jun 1.

Abstract

Atherosclerotic disease, including stroke and myocardial infarction, is the leading cause of morbidity and mortality worldwide. Atherosclerotic plaque formation occurs in the setting of excess oxidative and hemodynamic stress and is perpetuated by smoking, poor diet, dyslipidemia, hypertension, and diabetes. Plaque may rupture, resulting in acute thrombotic events. Smoking cessation, lifestyle modification, risk factor optimization, and antithrombotic therapies are the mainstays of atherosclerotic disease management and are the cornerstones to reduce morbidity and mortality in this high-risk patient population. Novel therapeutics are in development and will add to the growing armamentarium available to physicians who manage atherosclerotic disease.

摘要

动脉粥样硬化性疾病,包括中风和心肌梗死,是全球发病率和死亡率的主要原因。在氧化应激和血液动力学应激过度的情况下会发生动脉粥样硬化斑块形成,并由吸烟、不良饮食、血脂异常、高血压和糖尿病等因素持续存在。斑块可能破裂,导致急性血栓形成事件。戒烟、生活方式改变、危险因素优化和抗血栓治疗是动脉粥样硬化性疾病管理的主要方法,也是降低高危患者人群发病率和死亡率的基石。新的治疗方法正在开发中,并将为治疗动脉粥样硬化性疾病的医生提供更多的治疗手段。

相似文献

1
Atherosclerotic Disease: Pathogenesis and Approaches to Management.
Med Clin North Am. 2023 Sep;107(5):793-805. doi: 10.1016/j.mcna.2023.04.004. Epub 2023 Jun 1.
2
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401.
3
Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
Circulation. 2024 Aug 27;150(9):687-705. doi: 10.1161/CIRCULATIONAHA.123.067931. Epub 2024 Jun 17.
4
Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice.
Atherosclerosis. 2015 Sep;242(1):288-94. doi: 10.1016/j.atherosclerosis.2015.07.025. Epub 2015 Jul 15.
7
Medical Management of Peripheral Artery Disease.
Cardiol Clin. 2021 Nov;39(4):471-482. doi: 10.1016/j.ccl.2021.06.001.
8
Contemporary Medical Management of Peripheral Artery Disease.
Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10.
10
Biomechanical structural stresses of atherosclerotic plaques.
Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1469-81. doi: 10.1586/erc.10.130.

引用本文的文献

4
The Prevalence of Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes in Jordan: The PACT-MEA Study.
Diabetes Ther. 2025 May;16(5):899-913. doi: 10.1007/s13300-025-01718-7. Epub 2025 Mar 19.
5
Trends in atherosclerotic heart disease-related mortality among U.S. adults aged 35 and older: A 22-year analysis.
Int J Cardiol Cardiovasc Risk Prev. 2025 Feb 10;24:200374. doi: 10.1016/j.ijcrp.2025.200374. eCollection 2025 Mar.
6
Antioxidant and Anti-Inflammatory Effects of Bioactive Compounds in Atherosclerosis.
Int J Mol Sci. 2025 Feb 6;26(3):1379. doi: 10.3390/ijms26031379.
8
CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment.
Cells. 2025 Jan 17;14(2):131. doi: 10.3390/cells14020131.

本文引用的文献

1
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
2
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.
N Engl J Med. 2022 Nov 17;387(20):1855-1864. doi: 10.1056/NEJMoa2211023. Epub 2022 Nov 6.
3
P2Y inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials.
Eur Heart J Open. 2022 Mar 21;2(2):oeac019. doi: 10.1093/ehjopen/oeac019. eCollection 2022 Mar.
6
Targeting the Inflammasome in Cardiovascular Disease.
JACC Basic Transl Sci. 2021 Nov 3;7(1):84-98. doi: 10.1016/j.jacbts.2021.08.006. eCollection 2022 Jan.
8
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes.
Diabetes Spectr. 2021 Aug;34(3):248-256. doi: 10.2337/ds20-0067. Epub 2021 Aug 18.
9
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.
Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10.
10
Targeting inflammation in atherosclerosis - from experimental insights to the clinic.
Nat Rev Drug Discov. 2021 Aug;20(8):589-610. doi: 10.1038/s41573-021-00198-1. Epub 2021 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验